advertisement
1.5 Glaucomas as cause of blindness (20)
Showing records 1 to 20
Display all abstracts in classification 1.5 Glaucomas as cause of blindness
Search within classification 1.5 Glaucomas as cause of blindness90835 Blindness short after treatment of acute primary angle closure in China
Li S
British Journal of Ophthalmology 2021; 105: 502-506
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Yamada M
Journal of Medical Economics 2020; 23: 1293-1301
90530 Agreement amongst consultant ophthalmologists on levels of visual disability required for eligibility for certificate of sight impairment : Sight impairment registration using binocular composite visual fields
Jawaid I
Eye 2021; 35: 1644-1650
90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
Mokhles P
Eye 2021; 35: 883-891
90835 Blindness short after treatment of acute primary angle closure in China
Tang G
British Journal of Ophthalmology 2021; 105: 502-506
90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
van Gorcom L
Eye 2021; 35: 883-891
90530 Agreement amongst consultant ophthalmologists on levels of visual disability required for eligibility for certificate of sight impairment : Sight impairment registration using binocular composite visual fields
Stead RE
Eye 2021; 35: 1644-1650
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Nakano T
Journal of Medical Economics 2020; 23: 1293-1301
90530 Agreement amongst consultant ophthalmologists on levels of visual disability required for eligibility for certificate of sight impairment : Sight impairment registration using binocular composite visual fields
Rotchford AR
Eye 2021; 35: 1644-1650
90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
Schouten JSAG
Eye 2021; 35: 883-891
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Matsuda H
Journal of Medical Economics 2020; 23: 1293-1301
90835 Blindness short after treatment of acute primary angle closure in China
Fan SJ
British Journal of Ophthalmology 2021; 105: 502-506
90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
Berendschot TTJM
Eye 2021; 35: 883-891
90530 Agreement amongst consultant ophthalmologists on levels of visual disability required for eligibility for certificate of sight impairment : Sight impairment registration using binocular composite visual fields
King AJ
Eye 2021; 35: 1644-1650
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Kim SW
Journal of Medical Economics 2020; 23: 1293-1301
90835 Blindness short after treatment of acute primary angle closure in China
Zhai G
British Journal of Ophthalmology 2021; 105: 502-506
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Takagi Y
Journal of Medical Economics 2020; 23: 1293-1301
90835 Blindness short after treatment of acute primary angle closure in China
Lv J
British Journal of Ophthalmology 2021; 105: 502-506
90063 Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients
Beckers HJM; Webers CAB
Eye 2021; 35: 883-891
90835 Blindness short after treatment of acute primary angle closure in China
Zhang H; Lu W; Jiang J; Lv A; Wang N; Cao K; Zhao J; Vu V; Mu D; Pan X; Feng H; Hsia YC; Han Y
British Journal of Ophthalmology 2021; 105: 502-506